Pre-order Enquiry
Request Free Sample
Global Influenza (Flu) Antiviral Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18698609 | Publishing Date : 06-Jul-2021 | No. of pages : 110
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Influenza (Flu) Antiviral Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Influenza (Flu) Antiviral Drugs1.1 Influenza (Flu) Antiviral Drugs Market Overview
1.1.1 Influenza (Flu) Antiviral Drugs Product Scope
1.1.2 Influenza (Flu) Antiviral Drugs Market Status and Outlook
1.2 Global Influenza (Flu) Antiviral Drugs Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Influenza (Flu) Antiviral Drugs Market Size by Region (2016-2027)
1.4 Global Influenza (Flu) Antiviral Drugs Historic Market Size by Region (2016-2021)
1.5 Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Influenza (Flu) Antiviral Drugs Market Size (2016-2027)
1.6.1 North America Influenza (Flu) Antiviral Drugs Market Size (2016-2027)
1.6.2 Europe Influenza (Flu) Antiviral Drugs Market Size (2016-2027)
1.6.3 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size (2016-2027)
1.6.4 Latin America Influenza (Flu) Antiviral Drugs Market Size (2016-2027)
1.6.5 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size (2016-2027)
2 Influenza (Flu) Antiviral Drugs Market Overview by Type
2.1 Global Influenza (Flu) Antiviral Drugs Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Influenza (Flu) Antiviral Drugs Historic Market Size by Type (2016-2021)
2.3 Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Type (2022-2027)
2.4 Penetration and Dehulling Inhibitors
2.5 DNA Polymerase Inhibitors
2.6 Reverse Transcriptase Inhibitors
2.7 Protein Inhibitors
2.8 Neuraminidase Inhibitors
2.9 Broad-spectrum Antiviral Drugs
3 Influenza (Flu) Antiviral Drugs Market Overview by Application
3.1 Global Influenza (Flu) Antiviral Drugs Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Influenza (Flu) Antiviral Drugs Historic Market Size by Application (2016-2021)
3.3 Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Clinic
3.6 Household
3.7 Others
4 Influenza (Flu) Antiviral Drugs Competition Analysis by Players
4.1 Global Influenza (Flu) Antiviral Drugs Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2020)
4.3 Date of Key Players Enter into Influenza (Flu) Antiviral Drugs Market
4.4 Global Top Players Influenza (Flu) Antiviral Drugs Headquarters and Area Served
4.5 Key Players Influenza (Flu) Antiviral Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Influenza (Flu) Antiviral Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.1.4 Pfizer Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.1.5 Pfizer Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.2.4 Roche Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.2.5 Roche Recent Developments
5.3 Sanofi
5.5.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.3.4 Sanofi Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.4.4 Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.4.5 Johnson & Johnson Recent Developments
5.5 Merck & Co. (MSD)
5.5.1 Merck & Co. (MSD) Profile
5.5.2 Merck & Co. (MSD) Main Business
5.5.3 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.5.4 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.5.5 Merck & Co. (MSD) Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.6.4 Novartis Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.6.5 Novartis Recent Developments
5.7 AbbVie
5.7.1 AbbVie Profile
5.7.2 AbbVie Main Business
5.7.3 AbbVie Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.7.4 AbbVie Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.7.5 AbbVie Recent Developments
5.8 Gilead Sciences
5.8.1 Gilead Sciences Profile
5.8.2 Gilead Sciences Main Business
5.8.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.8.4 Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.8.5 Gilead Sciences Recent Developments
5.9 GlaxoSmithKline (GSK)
5.9.1 GlaxoSmithKline (GSK) Profile
5.9.2 GlaxoSmithKline (GSK) Main Business
5.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.9.4 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.9.5 GlaxoSmithKline (GSK) Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.10.4 Amgen Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.10.5 Amgen Recent Developments
5.11 AstraZeneca
5.11.1 AstraZeneca Profile
5.11.2 AstraZeneca Main Business
5.11.3 AstraZeneca Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.11.4 AstraZeneca Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.11.5 AstraZeneca Recent Developments
5.12 Bristol-Myers Squibb
5.12.1 Bristol-Myers Squibb Profile
5.12.2 Bristol-Myers Squibb Main Business
5.12.3 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.12.4 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.12.5 Bristol-Myers Squibb Recent Developments
5.13 Eli Lilly
5.13.1 Eli Lilly Profile
5.13.2 Eli Lilly Main Business
5.13.3 Eli Lilly Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.13.4 Eli Lilly Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.13.5 Eli Lilly Recent Developments
5.14 Teva
5.14.1 Teva Profile
5.14.2 Teva Main Business
5.14.3 Teva Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.14.4 Teva Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.14.5 Teva Recent Developments
5.15 Bayer
5.15.1 Bayer Profile
5.15.2 Bayer Main Business
5.15.3 Bayer Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.15.4 Bayer Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.15.5 Bayer Recent Developments
5.16 Novo Nordisk
5.16.1 Novo Nordisk Profile
5.16.2 Novo Nordisk Main Business
5.16.3 Novo Nordisk Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.16.4 Novo Nordisk Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.16.5 Novo Nordisk Recent Developments
5.17 Allergan
5.17.1 Allergan Profile
5.17.2 Allergan Main Business
5.17.3 Allergan Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.17.4 Allergan Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.17.5 Allergan Recent Developments
5.18 Takeda
5.18.1 Takeda Profile
5.18.2 Takeda Main Business
5.18.3 Takeda Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.18.4 Takeda Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.18.5 Takeda Recent Developments
5.19 Boehringer Ingelheim
5.19.1 Boehringer Ingelheim Profile
5.19.2 Boehringer Ingelheim Main Business
5.19.3 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Products, Services and Solutions
5.19.4 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Revenue (US$ Million) & (2016-2021)
5.19.5 Boehringer Ingelheim Recent Developments
6 North America
6.1 North America Influenza (Flu) Antiviral Drugs Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Influenza (Flu) Antiviral Drugs Market Dynamics
11.1 Influenza (Flu) Antiviral Drugs Industry Trends
11.2 Influenza (Flu) Antiviral Drugs Market Drivers
11.3 Influenza (Flu) Antiviral Drugs Market Challenges
11.4 Influenza (Flu) Antiviral Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Influenza (Flu) Antiviral Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Influenza (Flu) Antiviral Drugs Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Influenza (Flu) Antiviral Drugs Market Size Share by Region (2016-2021)
Table 4. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Influenza (Flu) Antiviral Drugs Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Influenza (Flu) Antiviral Drugs Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2022-2027)
Table 11. Global Influenza (Flu) Antiviral Drugs Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Influenza (Flu) Antiviral Drugs Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Application (2022-2027)
Table 16. Global Influenza (Flu) Antiviral Drugs Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2020)
Table 19. Date of Key Manufacturers Enter into Influenza (Flu) Antiviral Drugs Market
Table 20. Global Influenza (Flu) Antiviral Drugs Top Players Headquarters and Area Served
Table 21. Influenza (Flu) Antiviral Drugs Product Solution and Service
Table 22. Global Influenza (Flu) Antiviral Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Pfizer Basic Information List
Table 25. Pfizer Description and Business Overview
Table 26. Pfizer Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 27. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Pfizer (2016-2021)
Table 28. Pfizer Recent Developments
Table 29. Roche Basic Information List
Table 30. Roche Description and Business Overview
Table 31. Roche Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 32. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Roche (2016-2021)
Table 33. Roche Recent Developments
Table 34. Sanofi Basic Information List
Table 35. Sanofi Description and Business Overview
Table 36. Sanofi Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 37. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Sanofi (2016-2021)
Table 38. Sanofi Recent Developments
Table 39. Johnson & Johnson Basic Information List
Table 40. Johnson & Johnson Description and Business Overview
Table 41. Johnson & Johnson Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 42. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Johnson & Johnson (2016-2021)
Table 43. Johnson & Johnson Recent Developments
Table 44. Merck & Co. (MSD) Basic Information List
Table 45. Merck & Co. (MSD) Description and Business Overview
Table 46. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Merck & Co. (MSD) (2016-2021)
Table 48. Merck & Co. (MSD) Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Novartis (2016-2021)
Table 53. Novartis Recent Developments
Table 54. AbbVie Basic Information List
Table 55. AbbVie Description and Business Overview
Table 56. AbbVie Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of AbbVie (2016-2021)
Table 58. AbbVie Recent Developments
Table 59. Gilead Sciences Basic Information List
Table 60. Gilead Sciences Description and Business Overview
Table 61. Gilead Sciences Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Gilead Sciences (2016-2021)
Table 63. Gilead Sciences Recent Developments
Table 64. GlaxoSmithKline (GSK) Basic Information List
Table 65. GlaxoSmithKline (GSK) Description and Business Overview
Table 66. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of GlaxoSmithKline (GSK) (2016-2021)
Table 68. GlaxoSmithKline (GSK) Recent Developments
Table 69. Amgen Basic Information List
Table 70. Amgen Description and Business Overview
Table 71. Amgen Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Amgen (2016-2021)
Table 73. Amgen Recent Developments
Table 74. AstraZeneca Basic Information List
Table 75. AstraZeneca Description and Business Overview
Table 76. AstraZeneca Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of AstraZeneca (2016-2021)
Table 78. AstraZeneca Recent Developments
Table 79. Bristol-Myers Squibb Basic Information List
Table 80. Bristol-Myers Squibb Description and Business Overview
Table 81. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Bristol-Myers Squibb (2016-2021)
Table 83. Bristol-Myers Squibb Recent Developments
Table 84. Eli Lilly Basic Information List
Table 85. Eli Lilly Description and Business Overview
Table 86. Eli Lilly Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 87. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Eli Lilly (2016-2021)
Table 88. Eli Lilly Recent Developments
Table 89. Teva Basic Information List
Table 90. Teva Description and Business Overview
Table 91. Teva Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 92. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Teva (2016-2021)
Table 93. Teva Recent Developments
Table 94. Bayer Basic Information List
Table 95. Bayer Description and Business Overview
Table 96. Bayer Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 97. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Bayer (2016-2021)
Table 98. Bayer Recent Developments
Table 99. Novo Nordisk Basic Information List
Table 100. Novo Nordisk Description and Business Overview
Table 101. Novo Nordisk Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 102. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Novo Nordisk (2016-2021)
Table 103. Novo Nordisk Recent Developments
Table 104. Allergan Basic Information List
Table 105. Allergan Description and Business Overview
Table 106. Allergan Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 107. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Allergan (2016-2021)
Table 108. Allergan Recent Developments
Table 109. Takeda Basic Information List
Table 110. Takeda Description and Business Overview
Table 111. Takeda Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 112. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Takeda (2016-2021)
Table 113. Takeda Recent Developments
Table 114. Boehringer Ingelheim Basic Information List
Table 115. Boehringer Ingelheim Description and Business Overview
Table 116. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Products, Services and Solutions
Table 117. Revenue (US$ Million) in Influenza (Flu) Antiviral Drugs Business of Boehringer Ingelheim (2016-2021)
Table 118. Boehringer Ingelheim Recent Developments
Table 119. North America Influenza (Flu) Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 120. North America Influenza (Flu) Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 121. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 122. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 123. Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 124. Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 125. Asia-Pacific Influenza (Flu) Antiviral Drugs Market Share by Region (2016-2021)
Table 126. Asia-Pacific Influenza (Flu) Antiviral Drugs Market Share by Region (2022-2027)
Table 127. Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 128. Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 129. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Players (2016-2021) & (US$ Million)
Table 130. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 131. Influenza (Flu) Antiviral Drugs Market Trends
Table 132. Influenza (Flu) Antiviral Drugs Market Drivers
Table 133. Influenza (Flu) Antiviral Drugs Market Challenges
Table 134. Influenza (Flu) Antiviral Drugs Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza (Flu) Antiviral Drugs Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Influenza (Flu) Antiviral Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Influenza (Flu) Antiviral Drugs Market Share by Regions: 2021 VS 2027
Figure 4. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Influenza (Flu) Antiviral Drugs Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Influenza (Flu) Antiviral Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Influenza (Flu) Antiviral Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Influenza (Flu) Antiviral Drugs Market Size Share by Type in 2021 & 2027
Figure 11. Penetration and Dehulling Inhibitors Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. DNA Polymerase Inhibitors Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Reverse Transcriptase Inhibitors Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Protein Inhibitors Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Neuraminidase Inhibitors Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Broad-spectrum Antiviral Drugs Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Global Influenza (Flu) Antiviral Drugs Market Size Share by Application in 2021 & 2027
Figure 18. Hospital Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Clinic Market Size (US$ Million) YoY Growth (2016-2027)
Figure 20. Household Market Size (US$ Million) YoY Growth (2016-2027)
Figure 21. Others Market Size (US$ Million) YoY Growth (2016-2027)
Figure 22. Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Top 5 and Top 10 Players Influenza (Flu) Antiviral Drugs Market Share in 2020
Figure 24. North America Influenza (Flu) Antiviral Drugs Market Share by Country (2016-2027)
Figure 25. United States Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 26. Canada Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 27. Germany Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 28. France Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 29. U.K. Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 30. Italy Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 31. Russia Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 32. Nordic Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 33. Rest of Europe Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Influenza (Flu) Antiviral Drugs Market Share by Region (2016-2027)
Figure 35. China Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 36. Japan Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 37. South Korea Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 38. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 39. India Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 40. Australia Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 41. Rest of Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 42. Latin America Influenza (Flu) Antiviral Drugs Market Share by Country (2016-2027)
Figure 43. Mexico Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 44. Brazil Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 45. Rest of Latin America Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 46. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Share by Country (2016-2027)
Figure 47. Turkey Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 48. Saudi Arabia Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 49. UAE Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 50. Rest of Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size (2016-2027) & (US$ Million)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Keyplayers in Global Influenza (Flu) Antiviral Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
PfizerRoche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
